e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Lumping and splitting of fibrotic interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation?
K. Brown (Denver, United States of America)
Source:
International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Session:
Lumping and splitting of fibrotic interstitial lung diseases
Session type:
Symposium
Number:
3770
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Brown (Denver, United States of America). The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation?. International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The progressive fibrotic phenotype in fibrotic ILDs: the critical importance of observed disease behaviour
Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Year: 2019
Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition?
Source: Eur Respir J, 52 (2) 1801321; 10.1183/13993003.01321-2018
Year: 2018
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
Aspergillus
-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020
Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Early radiologic diagnose and assessment of lung parenchyma in patients with mild COPD and constant progressive smoking
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007
HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Does lung function predict response to therapy in PAH associated with connective tissue disease?
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 578s
Year: 2007
The airspace dimension test – A new way to diagnose emphysema?
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept